The inaugural Neuromuscular Drug Development Summit is the industry’s first dedicated discussion and networking forum focused on bringing together neuromuscular thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing. With the mission to enable drug developers to solve the challenges in bringing truly transformative therapeutics to market.
Download the full event guide here to view the complete agenda and companies speaking.
Developed in combination with experts from Sarepta, Novartis, Sanofi and other leading organisations, this industry-focused forum allows you to explore overcoming limited patient populations, innovations within gene therapy and the use of biomarkers and endpoints for increased efficacy in clinical trials to name a few.
Leave NMD with a deeper understanding of the clinical, preclinical and regulatory landscape surrounding neuromuscular drug development.
“I was impressed by many of the speakers and learnt a significant amount, which I was able to bring back to our discovery team.”
Stephen Krause, Senior Principal Scientist, Eisai
“Excellent networking and learning opportunity for pharma scientists.”
Matthew Kennedy, Director, Merck
“The quality of talks was high and the discussion very interesting.”
Claudio Babiloni, Associate Professor, University of Rome